Ken Kersemans
- Radiology, Nuclear Medicine and Imaging top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine
- Oncology
- Biochemistry top 5%
- Co-authors
- Filip De VosVeerle KersemansBart CornelissenJohn MertensMatthias BauwensChristian VanhoveKathia De ManPeter Dubruel
- Topics
- Radiopharmaceutical Chemistry and Applications (19 papers)Amino Acid Enzymes and Metabolism (16 papers)Medical Imaging Techniques and Applications (11 papers)
- Partner nations
- BelgiumGermanyUnited Kingdom
In The Last Decade
Ken Kersemans
48 papers receiving 597 citations
Peers
Comparison fields: 5 of 83
- Radiology, Nuclear Medicine and Imaging 215
- Molecular Biology 169
- Pulmonary and Respiratory Medicine 135
- Oncology 119
- Biochemistry 94
Countries citing papers authored by Ken Kersemans
This map shows the geographic impact of Ken Kersemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Kersemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Kersemans more than expected).
Fields of papers citing papers by Ken Kersemans
This network shows the impact of papers produced by Ken Kersemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Kersemans. The network helps show where Ken Kersemans may publish in the future.
Co-authorship network of co-authors of Ken Kersemans
This figure shows the co-authorship network connecting the top 25 collaborators of Ken Kersemans. A scholar is included among the top collaborators of Ken Kersemans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Kersemans. Ken Kersemans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 15 | |
| 3 | 16 | |
| 4 | 13 | |
| 5 | 22 | |
| 6 | 36 | |
| 7 | 23 | |
| 8 | 33 | |
| 9 | 15 | |
| 10 | 88 | |
| 11 | 1 | |
| 12 | 20 | |
| 13 | 50 | |
| 14 | 5 | |
| 15 | 24 | |
| 16 | 29 | |
| 17 | 1 | |
| 18 | In vivo evaluation of [I-123]-2-Iodo-D-Phenylalanine in tumour inoculated athymic mice by means of SPECT as a potential diagnostic and radionuclide therapy tool. | 1 |
| 19 | Synthesis of [18F]-2-fluoromethylphenylalanine, a new potential tracer for tumor specific diagnosis in humans with PET | 1 |
| 20 | Radioiodo-D-2-I-Phenylalanine a new tumour specific tracer for diagnosis and systemic radionuclide therapy | 2 |
About Ken Kersemans
Ken Kersemans is a scholar working on Biochemistry, Pharmaceutical Science and Radiology, Nuclear Medicine and Imaging, having authored 48 papers that have together received 600 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (19 papers), Amino Acid Enzymes and Metabolism (16 papers) and Medical Imaging Techniques and Applications (11 papers). The work is most often cited by research in Biochemistry (94 citations), Radiology, Nuclear Medicine and Imaging (215 citations) and Pharmaceutical Science (56 citations). Ken Kersemans has collaborated with scholars based in Belgium, Germany and United Kingdom. Frequent co-authors include Filip De Vos, Veerle Kersemans, Bart Cornelissen, John Mertens, Matthias Bauwens, Christian Vanhove, Kathia De Man, Peter Dubruel, Sandra Van Vlierberghe and Ine Van Nieuwenhove. Their work appears in journals such as PLoS ONE, Scientific Reports and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.